Andrew C. Cannon

Andrew Cannon

Andrew C. Cannon

PhD in Biochemistry & Molecular Biology

NIH Ruth L. Kirschstein National Research Service Award Individual Predoctotal MD/PhD Fellowship (2018-2021)

The NIH National Cancer Institute (NCI) offers Kirschstein National Research Service Award Individual Predoctoral MD/PhD Fellowships (F30 NSRAs) to support promising doctoral candidates to perform dissertation research and training for an MD/PhD degree in a scientific health-related field relevant to the mission of the NCI. Andrew C. Cannon, an MD/PhD Scholar at UNMC, has been awarded a 3-year F30 NSRA from the NCI for his project entitled “CXCR3 in Pancreatic Cancer Progression and Metastasis.” Andrew is studying the role of the Gαi protein-coupled receptor CXCR3 and its cytokine ligands in promoting the progression of pancreatic ductal adenocarcinoma. Particular emphasis is placed on determining how these cytokines influence the anticancer immune response and the ability of cancer cells to metastasize.  Andrew completed his dissertation research under the direction of Surinder Batra, PhD, receiving the PhD degree in May 2020 and will subsequently complete the final two years of his medical school training at UNMC.